Latest Releases
U.S. Senator Tina Smith Joins Elizabeth Warren, Banking Committee Democrats in Pressing SEC Chair to Require Disclosure of Corporate Lobbying Expenditures
Washington, D.C. — Today, U.S. Senators Tina Smith (D – Minn.), Sherrod Brown (D-Ohio.), Jon Tester (D-Mont.) and John Fetterman (D-Pa.) signed onto a letter led by Senator Elizabeth Warren (D – Mass.) urging Gary Gensler, Chair of the U.S. Securities and Exchange Commission (SEC), to create new rules requiring public companies to disclose their spending on lobbying efforts. Public companies are not currently required to report information on the details of their lobbying to the SEC even as corporate lobbying expenditures reach record highs. “In 2022, total federal lobbying expenditures reached $4.1 billion – the highest since 2010. Amazon and Meta spent almost $20 million each to influence decision-making in Congress and across government agencies, while the U.S. Chamber of Commerce – which counts companies like JPMorgan Chase, Alphabet, and Chevron among its members – spent $79.4 million,” wrote the senators. “While these figures are staggering, they provide little insight into the interests that companies spend millions each year to advance. This lack of transparency erodes the ability of everyday investors to make informed decisions about where to invest their money – and where their money goes once they have invested.” Specifically, the senators are requesting that such rules require disclosure of lobbying strategy, the total amount of direct or indirect contributions to registered state and federal lobbyists and any material risks related to or arising from lobbying strategies and expenditures. The senators requested the SEC provide them with details on their plans to develop and issue such rules no later than
U.S. Senators Tina Smith, Tom Cotton Reintroduce Bipartisan Legislation to Boost U.S. Pharmaceutical Manufacturing
WASHINGTON, D.C. — Today, Senators Tina Smith (D-MN) and Tom Cotton (R-AR) reintroduced bipartisan legislation to reduce dependence on foreign pharmaceutical manufacturing and boost production in the U.S. The pandemic exposed our nation’s dependence on other countries for essential prescription drugs. Seventy-seven percent of key pharmaceutical ingredients come from overseas, including from China, threatening the security of the supply chain and leading to shortages of essential prescription drugs. The American Made Pharmaceuticals Act would reduce our dependence on foreign countries for pharmaceuticals by boosting production here at home. The legislation would create federal incentives to onshore manufacturing of essential medicine, while taking steps to shore up links in the supply chain. “We know that depending on foreign countries for key resources – whether it’s oil or medicine – leaves us vulnerable to global supply chain shocks and shortages,” said Sen. Smith. “This bipartisan legislation would reduce our dependence on foreign pharmaceutical manufacturing and help boost production here at home. I look forward to getting this bill across the finish line so we can relieve prescription drug shortages and build more resilient supply chains.” “The Chinese Communist Party threatened to cut off America’s access to vital drugs during the pandemic,” said Sen. Cotton. “It’s time to bolster onshore manufacturing of pharmaceuticals to ensure Americans never have to rely on China for lifesaving medicine.” “Amneal applauds Senators Smith and Cotton on their targeted approach to increase pharmaceutical manufacturing here in the United States,” said Chirag Patel, President & Co-CEO of Amneal Pharmaceuticals. “Ensuring that
Senators Warren, Murray, and Smith Raise Further Questions About the FDA’s Oversight of Digital Health Devices
Washington, DC – United States Senator Elizabeth Warren (D-Mass.), member of the U.S. Senate Health, Education, Labor, and Pensions (HELP) Committee, U.S. Senate HELP Committee Ranking Member Patty Murray (D-Wash.), and Senator Tina Smith (D-Minn.), member of the U.S. Senate HELP Committee, sent a letter to the U.S. Food and Drug Administration (FDA) requesting additional information from the agency regarding its Software Precertification (Pre-Cert) Pilot Program. The FDA established the Pre-Cert Pilot Program in 2017 to test the feasibility of a “precertification” system for developers of software as a medical device (SaMD), such as mobile health apps, medical software, and health information technology.
U.S. Sen. Tina Smith Urges Regulators to Protect Key Data Used For Community Planning, Fighting Discrimination
WASHINGTON, D.C. [10/25/2019]—U.S. Senator Tina Smith (D-Minn.)—who has been holding meetings to discuss the need for affordable housing across Minnesota—and her Democratic Senate Banking Committee colleagues are demanding that the Consumer Financial Protection Bureau (CFPB) continues to collect vital information designed to determine whether financial institutions are serving the housing needs of their communities, identifying possible discriminatory lending and enforcing antidiscrimination laws. The CFPB has proposed to end the collection of some Home Mortgage Disclosure Act (HMDA) data that is currently collected on home mortgages. This data is one of the primary tools to measure trends and disparities in mortgage
In Wake of Difficult Weather, U.S. Senator Tina Smith Encourages Minnesota Farmers Experiencing Harvest Delays to Contact Crop Insurance Agents
WASHINGTON, D.C. [10/25/19]— U.S. Senator Tina Smith (D-Minn.) is encouraging Minnesota farmers participating in federal crop insurance to request more time to harvest after extremely wet and snowy conditions this fall forced many to experience delays. “It’s absolutely critical that we do everything we can to support farmers who’ve been facing bad weather, trade uncertainty and low commodity prices,” said Sen. Smith, a member of the Senate Agriculture Committee. “If you are a farmer with crop insurance, I urge you to contact your insurance agent to request more time to harvest. And I’ll keep working to bring stability and predictability to Minnesota Ag.”
U.S. Sens. Tina Smith & Susan Collins: Bipartisan Resolution Recognizes October as National Principals Month
WASHINGTON, D.C. [10/25/2019]—U.S. Senators Tina Smith (D-Minn.) and Susan Collins (R-Maine)—both members of the Senate Education Committee—are pleased that their bipartisan resolution declaring October 2019 as National Principals Month passed the Senate. This resolution recognizes the important role principals play in ensuring that every child has access to a high-quality education. “School principals are community builders, academic leaders, facility managers and so much more,” said Sen. Smith. “They’re responsible for creating school environments where every child can succeed, and where teachers and faculty can get the support they need to educate students and help shape them into future leaders. We need to do all we can to
English